相关实验视频

Updated: Sep 17, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

三重阴性乳腺癌在上升:突破和超越

Alex Agelidis^1,2, Anna Ter-Zakarian¹, Mohammed Jaloudi¹

¹Scripps Cancer Center, Scripps Health, La Jolla, California, USA.

Breast cancer (Dove Medical Press)

|July 2, 2025

概括

三阴性乳腺癌 (TNBC) 是具有侵略性的,年轻女性的发病率不断上升. 针对性疗法,免疫疗法和诊断方面的进展正在改善TNBC的个性化治疗方法.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

三阴性乳腺癌 (TNBC) 是一种具有不良预后的侵袭性亚型.
青春期TNBC不成比例地影响年轻女性,并表现出显著的人口差异.
有限的向治疗选择在历史上定义了TNBC管理.

研究的目的:

审查TNBC中日益增长的发病率和人口差异.
讨论TNBC的分子格局和向疗法开发.
综合TNBC诊断和治疗的最新创新和趋势.

主要方法:

关于TNBC最近改变实践的研究的文献综述.
对涉及TNBC的分子和遗传途径的分析.
评估新的生物标志物和诊断方面的进展.

主要成果:

免疫检查点抑制剂和针对特定TNBC亚型的PARP抑制剂的整合.
引入抗体药物合物作为有效的治疗选择.
诊断方面的进步,包括机器学习和空间转录学,使个性化医学成为可能.

结论:

新兴的疗法和诊断工具正在改变TNBC治疗模式.
个性化的方法正在成为管理TNBC的核心.
持续的研究对于解决TNBC异质性和改善结果至关重要.

关键词:

美国TNBC电视台诊断诊断诊断诊断诊断诊断基因组学就是基因组学.免疫疗法免疫疗法医学医学医学医学医学瘤学在瘤学方面.治疗药物治疗药物

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...